Clinical Cancer Research Published a Key Study on the Clinical Validity of OncoMasTR Conducted by Researchers from The Institute of Cancer Research, Royal Marsden Hospital and Queen Mary University of London.

OncoMark founder and Chief Scientific Officer Professor William Gallagher has been announced as winner of the prestigious 2019 Science Foundation Ireland (SFI) Entrepreneurship Award at the annual SFI Science Summit held in Athlone.

OncoMark to Present Key Study on OncoMasTR Test for Early Stage Breast Cancer at ASCO 2019 in Chicago. Presentation will highlight superior clinical performance of the OncoMasTR test in Irish patients enrolled in the TAILORx Trial.

OncoMark Announces Results of Key Studies on Clinical Performance of Prognostic Test for Early Stage Breast Cancer. OncoMark Ltd, an Irish diagnostics company, today announced the results of two key studies on the clinical performance of its OncoMasTR test.